CellaVision AB (LTS:0MR5)
kr 239.25 0 (0%) Market Cap: 5.80 Bil Enterprise Value: 5.69 Bil PE Ratio: 37.03 PB Ratio: 7.24 GF Score: 93/100

Q3 2021 CellaVision AB Earnings Call Transcript

Oct 22, 2021 / 09:00AM GMT
Release Date Price: kr444.1 (+6.55%)
Operator

Ladies and gentlemen, welcome to the CellaVision Audiocast with Teleconference Q3 2021. (Operator Instructions)

Today, I am pleased to present CEO, Simon Ãstergaard. Please begin your meeting.

Simon Ã;stergaard;publ;CEO;President
CellaVision AB

()-&

Thank you very much. And good morning, good afternoon, everybody on the call. I'm Simon Ãstergaard, CEO of CellaVision. I have my CFO, Magnus Blixt, with me. I'm pleased to present our interim Q3 report today. I'll briefly give a short company/market introduction leading into our Q3 financials and a bit how we interpret the current market situation. And then as said, we are very happy to take any questions.

Next slide, please. In fact, 2 slides forward. Yes, Slide #3. I will continue as we get the technology sorted.

So just a brief introduction on CellaVision. CellaVision is operating within the field of hematology, so blood-based analysis. We are -- our vision is to be a leader in global digitalization of automated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot